1. MAPK/ERK Pathway Stem Cell/Wnt Apoptosis
  2. ERK Ferroptosis
  3. JWG-045

JWG-045 是一种选择性的 ERK5 抑制剂。JWG-045 具有独立于 ERK5 抑制的、特有的、抗铁死亡 (ferroptosis) 活性。JWG-045 可用于乳腺癌的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

JWG-045

JWG-045 Chemical Structure

CAS No. : 1234480-61-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 ERK 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

JWG-045 is a selective ERK5 inhibitor. JWG-045 exhibits unique ferroptosis-resistant activity independent of ERK5 inhibition. JWG-045 can be used in breast cancer research[1].

IC50 & Target[1]

ERK5

 

体外研究
(In Vitro)

JWG-045 (3 μM; 24 h) 可轻度降低 BT474 细胞的细胞密度,并可保护 BT474 和 MDA-MB-231 乳腺癌细胞免受 RSL3 诱导的铁死亡[1]
JWG-045 (3 μM; 24 h) 可保护 ERK5 沉默的 MDA-MB-231 三阴性乳腺癌细胞免受 RSL3 诱导的铁死亡,且该作用独立于 ERK5 的表达[1]
JWG-045 (3 μM; 6 days) 可降低 Trastuzumab (HY-P9907) 耐药性 BT474 乳腺癌细胞的细胞密度,并恢复其对 Trastuzumab 的敏感性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: BT474 luminal B breast cancer cells, MDA-MB-231 triple-negative breast cancer cells
Concentration: 3 μM (single treatment; pre-incubated then combined with RSL3)
Incubation Time: 24 h (single treatment; total incubation with RSL3); 20 h (live-cell imaging)
Result: Caused a modest, statistically significant reduction in BT474 cell density.
Reduced RSL3-induced cytotoxicity in both BT474 and MDA-MB-231 cells, significantly increasing cell density compared to RSL3 alone.
Prevented the time-dependent decrease in BT474 cell confluency induced by RSL3 over 20 hours.

Cell Viability Assay[1]

Cell Line: ERK5-silenced MDA-MB-231 triple-negative breast cancer cells
Concentration: 3 μM (alone; combined with RSL3)
Incubation Time: 24 h
Result: Blocked RSL3-induced ferroptotic death in both control and ERK5-silenced MDA-MB-231 cells, significantly increasing cell density compared to RSL3 alone.

Cell Proliferation Assay[1]

Cell Line: Trastuzumab-resistant BT474 breast cancer cells
Concentration: 3 μM (alone; combined with Trastuzumab)
Incubation Time: 6 days
Result: Reduced BT474 cell density.
Restored the growth inhibitory effect of trastuzumab in Trastuzumab-resistant BT474 cells to the level achieved by Trastuzumab monotherapy in parental BT474 cells.
分子量

487.60

Formula

C27H33N7O2

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
JWG-045
目录号:
HY-181968
需求量: